Oracle Investment Management Inc Codiak Bio Sciences, Inc. Transaction History

Oracle Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.24 - $6.96 $90,952 - $282,603	-40,604 Reduced 8.05%	463,998 $1.34 Million
Q1 2022 May 16, 2022	SELL	$4.3 - $12.95 $664,732 - $2 Million	-154,589 Reduced 23.45%	504,602 $3.16 Million
Q4 2021 Feb 14, 2022	SELL	$10.0 - $16.78 $408,090 - $684,775	-40,809 Reduced 5.83%	659,191 $7.34 Million
Q3 2021 Nov 15, 2021	BUY	$15.58 - $22.88 $331,854 - $487,344	21,300 Added 3.14%	700,000 $11.4 Million
Q2 2021 Aug 16, 2021	BUY	$11.72 - $26.81 $1.56 Million - $3.57 Million	133,340 Added 24.45%	678,700 $12.6 Million
Q1 2021 May 17, 2021	BUY	$13.49 - $31.53 $7.36 Million - $17.2 Million	545,360 New	545,360 $8.22 Million

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oracle Investment Management Inc with notifications on news.